JAHA:老年人心血管疾病危险因素和心血管事件的变化情况

2021-05-18 MedSci原创 MedSci原创

在没有CVD的老年人和年长的亚洲人群中,研究人员观察到CVH复合指标的改善与CVD风险降低之间存在一致的关系。体重指数和总胆固醇不足以预测老年人和年长人群的全因死亡率。

近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,这项研究调查了亚洲老年人群中心血管健康(CVH)状况的变化以及这些变化是否与心血管疾病(CVD)和死亡率有关。

研究人员对韩国国民健康保险局中208673名年龄60岁以上既往无CVD的高龄人群进行了评估,其中包含109431名CVH状态改变的参与者。从2004年至2014年期间,研究人员对老年人(60-74岁)和年长(≥75岁)组的心血管危险因素变化与心血管事件的相关性进行了评估。

在随访期间(CVD为7.1年,死亡率为7.2年),共发生了19429起CVD事件和24225例死亡。在老年人和年长参与者中,较高的CVH状态可降低CVD和死亡的风险。

心血管疾病和死亡率热图

在年长的参与者中,与持续较低的CVH相比,持续较高的CVH(亚风险比为0.41;95%CI为0.23-0.73)与较低的CVD风险相关。在老年人群中始终观察到这种趋势。在年长的参与者中,总胆固醇水平不足以预测CVD事件。在老年人和年长人群中,体重指数和总胆固醇不足以预测全因死亡率。

由此可见,在没有CVD的老年人和年长的亚洲人群中,研究人员观察到CVH复合指标的改善与CVD风险降低之间存在一致的关系。体重指数和总胆固醇不足以预测老年人和年长人群的全因死亡率

原始出处:

Pil‐Sung Yang.et al.Changes in Cardiovascular Risk Factors and Cardiovascular Events in the Elderly Population.J AM HEART ASSOC.2021.https://www.ahajournals.org/doi/10.1161/JAHA.120.019482

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-20 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 俩米儿

    厉害了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2023769, encodeId=3cf52023e693a, content=<a href='/topic/show?id=9dfc518398d' target=_blank style='color:#2F92EE;'>#心血管疾病危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51839, encryptionId=9dfc518398d, topicName=心血管疾病危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Mon Nov 15 15:37:30 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643748, encodeId=7f5e1643e4824, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Thu Apr 21 19:37:30 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268536, encodeId=e8201268536f4, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498876, encodeId=013c14988e6ff, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Thu May 20 02:37:30 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966565, encodeId=3eb4966565f9, content=厉害了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d635318610, createdName=俩米儿, createdTime=Tue May 18 14:03:31 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966535, encodeId=c16c96653534, content=太棒了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=98921388706, createdName=hbh_st, createdTime=Tue May 18 11:53:48 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 hbh_st

    太棒了

    1

    展开1条回复

相关资讯

Eur Heart J:降低胆固醇、血压或两者同时降低在预防心血管事件的效果如何?

在无心血管疾病的患者中,与安慰剂相比,瑞舒伐他汀治疗以及收缩压升高患者降压治疗的CV收益在停止随机治疗后至少可持续3年。

JAHA:空气颗粒物污染与卒中或急性心肌梗塞成人心血管事件风险的关系

伴有CVD病史的成年人易受PM2.5暴露的影响,尤其是对CVD死亡率的影响。在PM2.5<12 µg/m3的暴露水平下观察到风险增加,表明当前的PM2.5法规水平可能对该易感人群没有保护作用。

J Intern Med:新型胶原因子Endotrophin可预测动脉粥样硬化患者的心血管事件和死亡风险

PRO‐C6存在于动脉粥样硬化斑块中,并与患者未来的心血管事件、心血管死亡和全因死亡风险相关

IBD:炎症性肠病的疾病活动与动脉血管疾病的发病率增加有关

尽管炎症性肠病(IBD)主要影响患者的肠道,但是作为一种全身性疾病也会影响身体的其他器官,包括静脉血栓栓塞症(VTE),葡萄膜炎和脓皮病坏疽等。

EHJCP:减肥药奥利司他可降低多种心血管事件的长期风险

减肥药奥利司他可降低多种心血管事件的长期风险

JAHA:尿酸、颈动脉内膜中层厚度和心血管事件之间的关联

在中高CVD风险的男性中,较低和较高SUA水平都与VE事件风险增加有关,但在女性中没有。只有升高的SUA水平可预测cIMT进展。